Imed Infinity Medical-Limited Partnership (TLV:IMED)
Israel
· Delayed Price · Currency is ILS · Price in ILA 114.00
+3.50 (3.17%)
Apr 28, 2026, 3:48 PM IDT
TLV:IMED Revenue
In the year 2025, Imed Infinity Medical-Limited Partnership had annual revenue of $226.00K USD with 451.22% growth. Imed Infinity Medical-Limited Partnership had revenue of $-431.00K in the half year ending December 31, 2025, with 14.93% growth.
Revenue
$226.00K
Revenue Growth
+451.22%
P/S Ratio
6.38
Revenue / Employee
$2.83K
Employees
80
Market Cap
4.60M ILS
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Danel (Adir Yeoshua) | 2.90B |
| Amal Holdings A.D. | 2.18B |
| BrainsWay | 166.49M |
| Bio-View | 19.93M |
| Can-Fite BioPharma | 1.29M |
| Erika Carmel-Tech | 37.34M |
| XTL Biopharmaceuticals | 3.26M |